Cargando…

Development of a Web-Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS-Hemo): Study Protocol

BACKGROUND: Individual pharmacokinetic assessment is a critical component of tailored prophylaxis for hemophilia patients. Population pharmacokinetics allows using individual sparse data, thus simplifying individual pharmacokinetic studies. Implementing population pharmacokinetics capacity for the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iorio, Alfonso, Keepanasseril, Arun, Foster, Gary, Navarro-Ruan, Tamara, McEneny-King, Alanna, Edginton, Andrea N, Thabane, Lehana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2016
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5200844/ https://www.ncbi.nlm.nih.gov/pubmed/27977390 http://dx.doi.org/10.2196/resprot.6558

Ejemplares similares

Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)
por: McEneny-King, Alanna, et al.
Publicado: (2016)

External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
por: Chelle, Pierre, et al.
Publicado: (2021)

Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis
por: McEneny-King, Alanna, et al.
Publicado: (2017)

Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database
por: Versloot, Olav, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019
por: McEneny-King, Alanna C., et al.
Publicado: (2021)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
por: Yu, Jacky K., et al.
Publicado: (2019)

Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
por: Brod, Meryl, et al.
Publicado: (2023)

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics
por: Zhou, Jenny Y., et al.
Publicado: (2019)

Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
por: Chelle, Pierre, et al.
Publicado: (2019)

Five new Lamiinae (Coleoptera, Cerambycidae) from Bolivia in honor of James E. Wappes
por: Galileo, Maria Helena M., et al.
Publicado: (2015)

Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study
por: Cheng, Ji, et al.
Publicado: (2016)

Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
por: Chelle, Pierre, et al.
Publicado: (2019)

Hemo-dynamics
por: Zamir, Mair
Publicado: (2016)

Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
por: Iorio, Alfonso, et al.
Publicado: (2018)

Focusing in on use of pharmacokinetic profiles in routine hemophilia care
por: Croteau, Stacy E., et al.
Publicado: (2018)

Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
por: Teitel, Jerome, et al.
Publicado: (2021)

HemoKinect: A Microsoft Kinect V2 Based Exergaming Software to Supervise Physical Exercise of Patients with Hemophilia
por: Mateo, Fernando, et al.
Publicado: (2018)

Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes
por: Croteau, Stacy E., et al.
Publicado: (2020)

Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study
por: Matino, Davide, et al.
Publicado: (2022)

Hemos perdido el reino
por: Campos, Marco Antonio, 1949-
Publicado: (1987)

Hemos perdido el sol /
por: Lera, Angel María de, 1912-
Publicado: (1966)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
por: Versloot, Olav, et al.
Publicado: (2022)

Role of creatine supplementation on exercise-induced cardiovascular function and oxidative stress
por: Kingsley, Michael IC, et al.
Publicado: (2009)

Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
por: Chen, Zhenping, et al.
Publicado: (2021)

Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature
por: Germini, Federico, et al.
Publicado: (2022)

Lycopene-rich diets modulate HDL functionality and associated inflammatory markers without affecting lipoprotein size and distribution in moderately overweight, disease-free, middle-aged adults: A randomized controlled trial
por: McEneny, Jane, et al.
Publicado: (2022)

Tratamiento Inicial del hemo y neumotorax traumatico :/
por: Golpe Gorgonio, Anatolio
Publicado: (1992)

Reliability of the HemoCue(® )hemoglobinometer in critically ill patients
por: Frasca, D, et al.
Publicado: (2010)

Hemo-Therapin—A Notable Advance in Intravenous Therapy
Publicado: (1917)

Corona, Acute Ischemic Stroke, Malignant Cerebral Edema, and Hemo-adsorption: A Case Report
por: Shah, Mehul, et al.
Publicado: (2022)

Web-Based Learning for Emergency Airway Management in Anesthesia Residency Training
por: Hindle, Ada, et al.
Publicado: (2015)

Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study
por: Cheng, Ji, et al.
Publicado: (2016)

A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes
por: Daniels, Jane-Ann, et al.
Publicado: (2014)

Hemophilia trials in the twenty‐first century: Defining patient important outcomes
por: Konkle, Barbara A., et al.
Publicado: (2019)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
por: Preijers, Tim, et al.
Publicado: (2020)

A Cross-Sectional Study Demonstrating Increased Serum Amyloid A Related Inflammation in High-Density Lipoproteins from Subjects with Type 1 Diabetes Mellitus and How This Association Was Augmented by Poor Glycaemic Control
por: McEneny, Jane, et al.
Publicado: (2015)

El mundo que hemos perdido, explorado de nuevo
por: Laslett, Peter
Publicado: (1987)

Function Coupling Mechanism of PhuS and HemO in Heme Degradation
por: Lee, Michael J. Y., et al.
Publicado: (2017)

Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
por: Shah, Anita, et al.
Publicado: (2019)

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
por: Solms, Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_44mub3ckj8nmq5knc0lm0ujj0q